55
Participants
Start Date
January 31, 2019
Primary Completion Date
September 15, 2021
Study Completion Date
September 15, 2021
BAY1213790
Single intravenous infusion of BAY1213790 (Two different doses)
0.9% sodium chloride solution
Single intravenous infusion of Placebo (0.9% sodium chloride solution)
UZ Brussel, Bruxelles - Brussel
UZ Leuven Gasthuisberg, Leuven
CHU de Charleroi Hôpital civil, Lodelinsart
Hospital Reina Sofía, Córdoba
Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela
Nova Clinical Research, LLC, Bradenton
Hospital Clínico Universitario de Valencia, Valencia
Hospital Universitario Dr. Peset, Valencia
Research by Design, LLC, Chicago
California Institute of Renal Research - Chula Vista, Chula Vista
Renal and Transplant Associates of New England, PC, Springfield
CHLO - Hospital Santa Cruz, Carnaxide
Pluribus Dialise - Cascais (DaVita), Cascais
CHMT - Hospital Rainha Santa Isabel, Torres Novas
Ciutat Sanitària i Universitària de Bellvitge, L'Hospitalet de Llobregat
Lead Sponsor
Bayer
INDUSTRY